NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
60 hedge funds and large institutions have $51.4M invested in NeuBase Therapeutics, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 17 increasing their positions, 18 reducing their positions, and 13 closing their positions.
Holders
60
Holders Change
+2
Holders Change %
+3.45%
% of All Funds
1.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
17
Reduced
18
Closed
13
Calls
$508K
Puts
$187K
Net Calls
+$321K
Net Calls Change
+$177K